Predicting the long-term outcome after idiopathic facial nerve paralysis
To investigate long-term recovery after Bell's palsy and evaluate specific parameters for predicting the long-term outcome of facial weakness. Retrospective clinical study combined with long-term follow-up. Tertiary care university hospital (Department of Otorhinolaryngology, Head and Neck Surg...
Gespeichert in:
Veröffentlicht in: | Otology & neurotology 2011-07, Vol.32 (5), p.848-851 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 851 |
---|---|
container_issue | 5 |
container_start_page | 848 |
container_title | Otology & neurotology |
container_volume | 32 |
creator | Mantsopoulos, Konstantinos Psillas, Georgios Psychogios, Georgios Brase, Cristoph Iro, Heinrich Constantinidis, Jannis |
description | To investigate long-term recovery after Bell's palsy and evaluate specific parameters for predicting the long-term outcome of facial weakness.
Retrospective clinical study combined with long-term follow-up.
Tertiary care university hospital (Department of Otorhinolaryngology, Head and Neck Surgery, University of Thessaloniki, Greece).
Forty-four patients who were followed up 2 to 6 years (mean, 4.01 yr) after the onset of facial weakness.
The failure rate of complete recovery was studied for age, initial nerve excitability test, electroneurography, initial severity of paralysis, and number of days from onset of facial weakness to the start of medical treatment.
Thirty-two (73%) of 44 patients had a satisfactory outcome, and 12 (27%) had a nonsatisfactory recovery. Initial House-Brackmann grades V/VI and electroneurographically detected degeneration of 90% or more were shown to affect the long-term outcome of facial weakness significantly (p = 0.024 and p = 0.000, respectively).
The initial severity of facial weakness and the electroneurographically detected facial nerve degeneration were found to be important factors in predicting the long-term prognosis of Bell's palsy. |
doi_str_mv | 10.1097/mao.0b013e31821da2c6 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_877405153</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>877405153</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-f910482a982bcdc3d9a264ab60266b205f83cf3c73c46980151531560084f7713</originalsourceid><addsrcrecordid>eNpdkMFOwzAMhiMEYmPwBgjlxqnDSZqkOU4TMCTQOMC5StNkC2qbkbRIe3s2Njhwsi39ny1_CF0TmBJQ8q7VYQoVEGYZKSipNTXiBI0JZzLLOfDTn55kklA1QhcpfQAQybg8RyNKBFeKwRgtXqOtvel9t8L92uImdKust7HFYehNaC3WbjdiX_uw0f3aG-y08brBnY1fFm901M02-XSJzpxukr061gl6f7h_my-y5-Xj03z2nBkmaZ85RSAvqFYFrUxtWK00FbmuBFAhKgrcFcw4ZiQzuVAFEL5_gguAIndSEjZBt4e9mxg-B5v6svXJ2KbRnQ1DKgspc9hDu2R-SJoYUorWlZvoWx23JYFyr7B8mS3L_wp32M3xwFC1tv6Dfp2xb5apbT0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>877405153</pqid></control><display><type>article</type><title>Predicting the long-term outcome after idiopathic facial nerve paralysis</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Mantsopoulos, Konstantinos ; Psillas, Georgios ; Psychogios, Georgios ; Brase, Cristoph ; Iro, Heinrich ; Constantinidis, Jannis</creator><creatorcontrib>Mantsopoulos, Konstantinos ; Psillas, Georgios ; Psychogios, Georgios ; Brase, Cristoph ; Iro, Heinrich ; Constantinidis, Jannis</creatorcontrib><description>To investigate long-term recovery after Bell's palsy and evaluate specific parameters for predicting the long-term outcome of facial weakness.
Retrospective clinical study combined with long-term follow-up.
Tertiary care university hospital (Department of Otorhinolaryngology, Head and Neck Surgery, University of Thessaloniki, Greece).
Forty-four patients who were followed up 2 to 6 years (mean, 4.01 yr) after the onset of facial weakness.
The failure rate of complete recovery was studied for age, initial nerve excitability test, electroneurography, initial severity of paralysis, and number of days from onset of facial weakness to the start of medical treatment.
Thirty-two (73%) of 44 patients had a satisfactory outcome, and 12 (27%) had a nonsatisfactory recovery. Initial House-Brackmann grades V/VI and electroneurographically detected degeneration of 90% or more were shown to affect the long-term outcome of facial weakness significantly (p = 0.024 and p = 0.000, respectively).
The initial severity of facial weakness and the electroneurographically detected facial nerve degeneration were found to be important factors in predicting the long-term prognosis of Bell's palsy.</description><identifier>ISSN: 1531-7129</identifier><identifier>EISSN: 1537-4505</identifier><identifier>DOI: 10.1097/mao.0b013e31821da2c6</identifier><identifier>PMID: 21659930</identifier><language>eng</language><publisher>United States</publisher><subject>Adolescent ; Adult ; Aged ; Bell Palsy - drug therapy ; Bell Palsy - physiopathology ; Child ; Child, Preschool ; Dextrans - therapeutic use ; Facial Nerve - physiopathology ; Female ; Follow-Up Studies ; Glucocorticoids - therapeutic use ; Humans ; Male ; Middle Aged ; Pentoxifylline - therapeutic use ; Phosphodiesterase Inhibitors - therapeutic use ; Prednisolone - therapeutic use ; Prognosis ; Recovery of Function - physiology ; Severity of Illness Index ; Treatment Outcome</subject><ispartof>Otology & neurotology, 2011-07, Vol.32 (5), p.848-851</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-f910482a982bcdc3d9a264ab60266b205f83cf3c73c46980151531560084f7713</citedby><cites>FETCH-LOGICAL-c372t-f910482a982bcdc3d9a264ab60266b205f83cf3c73c46980151531560084f7713</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21659930$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mantsopoulos, Konstantinos</creatorcontrib><creatorcontrib>Psillas, Georgios</creatorcontrib><creatorcontrib>Psychogios, Georgios</creatorcontrib><creatorcontrib>Brase, Cristoph</creatorcontrib><creatorcontrib>Iro, Heinrich</creatorcontrib><creatorcontrib>Constantinidis, Jannis</creatorcontrib><title>Predicting the long-term outcome after idiopathic facial nerve paralysis</title><title>Otology & neurotology</title><addtitle>Otol Neurotol</addtitle><description>To investigate long-term recovery after Bell's palsy and evaluate specific parameters for predicting the long-term outcome of facial weakness.
Retrospective clinical study combined with long-term follow-up.
Tertiary care university hospital (Department of Otorhinolaryngology, Head and Neck Surgery, University of Thessaloniki, Greece).
Forty-four patients who were followed up 2 to 6 years (mean, 4.01 yr) after the onset of facial weakness.
The failure rate of complete recovery was studied for age, initial nerve excitability test, electroneurography, initial severity of paralysis, and number of days from onset of facial weakness to the start of medical treatment.
Thirty-two (73%) of 44 patients had a satisfactory outcome, and 12 (27%) had a nonsatisfactory recovery. Initial House-Brackmann grades V/VI and electroneurographically detected degeneration of 90% or more were shown to affect the long-term outcome of facial weakness significantly (p = 0.024 and p = 0.000, respectively).
The initial severity of facial weakness and the electroneurographically detected facial nerve degeneration were found to be important factors in predicting the long-term prognosis of Bell's palsy.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Bell Palsy - drug therapy</subject><subject>Bell Palsy - physiopathology</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Dextrans - therapeutic use</subject><subject>Facial Nerve - physiopathology</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Glucocorticoids - therapeutic use</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Pentoxifylline - therapeutic use</subject><subject>Phosphodiesterase Inhibitors - therapeutic use</subject><subject>Prednisolone - therapeutic use</subject><subject>Prognosis</subject><subject>Recovery of Function - physiology</subject><subject>Severity of Illness Index</subject><subject>Treatment Outcome</subject><issn>1531-7129</issn><issn>1537-4505</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkMFOwzAMhiMEYmPwBgjlxqnDSZqkOU4TMCTQOMC5StNkC2qbkbRIe3s2Njhwsi39ny1_CF0TmBJQ8q7VYQoVEGYZKSipNTXiBI0JZzLLOfDTn55kklA1QhcpfQAQybg8RyNKBFeKwRgtXqOtvel9t8L92uImdKust7HFYehNaC3WbjdiX_uw0f3aG-y08brBnY1fFm901M02-XSJzpxukr061gl6f7h_my-y5-Xj03z2nBkmaZ85RSAvqFYFrUxtWK00FbmuBFAhKgrcFcw4ZiQzuVAFEL5_gguAIndSEjZBt4e9mxg-B5v6svXJ2KbRnQ1DKgspc9hDu2R-SJoYUorWlZvoWx23JYFyr7B8mS3L_wp32M3xwFC1tv6Dfp2xb5apbT0</recordid><startdate>201107</startdate><enddate>201107</enddate><creator>Mantsopoulos, Konstantinos</creator><creator>Psillas, Georgios</creator><creator>Psychogios, Georgios</creator><creator>Brase, Cristoph</creator><creator>Iro, Heinrich</creator><creator>Constantinidis, Jannis</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201107</creationdate><title>Predicting the long-term outcome after idiopathic facial nerve paralysis</title><author>Mantsopoulos, Konstantinos ; Psillas, Georgios ; Psychogios, Georgios ; Brase, Cristoph ; Iro, Heinrich ; Constantinidis, Jannis</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-f910482a982bcdc3d9a264ab60266b205f83cf3c73c46980151531560084f7713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Bell Palsy - drug therapy</topic><topic>Bell Palsy - physiopathology</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Dextrans - therapeutic use</topic><topic>Facial Nerve - physiopathology</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Glucocorticoids - therapeutic use</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Pentoxifylline - therapeutic use</topic><topic>Phosphodiesterase Inhibitors - therapeutic use</topic><topic>Prednisolone - therapeutic use</topic><topic>Prognosis</topic><topic>Recovery of Function - physiology</topic><topic>Severity of Illness Index</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mantsopoulos, Konstantinos</creatorcontrib><creatorcontrib>Psillas, Georgios</creatorcontrib><creatorcontrib>Psychogios, Georgios</creatorcontrib><creatorcontrib>Brase, Cristoph</creatorcontrib><creatorcontrib>Iro, Heinrich</creatorcontrib><creatorcontrib>Constantinidis, Jannis</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Otology & neurotology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mantsopoulos, Konstantinos</au><au>Psillas, Georgios</au><au>Psychogios, Georgios</au><au>Brase, Cristoph</au><au>Iro, Heinrich</au><au>Constantinidis, Jannis</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predicting the long-term outcome after idiopathic facial nerve paralysis</atitle><jtitle>Otology & neurotology</jtitle><addtitle>Otol Neurotol</addtitle><date>2011-07</date><risdate>2011</risdate><volume>32</volume><issue>5</issue><spage>848</spage><epage>851</epage><pages>848-851</pages><issn>1531-7129</issn><eissn>1537-4505</eissn><abstract>To investigate long-term recovery after Bell's palsy and evaluate specific parameters for predicting the long-term outcome of facial weakness.
Retrospective clinical study combined with long-term follow-up.
Tertiary care university hospital (Department of Otorhinolaryngology, Head and Neck Surgery, University of Thessaloniki, Greece).
Forty-four patients who were followed up 2 to 6 years (mean, 4.01 yr) after the onset of facial weakness.
The failure rate of complete recovery was studied for age, initial nerve excitability test, electroneurography, initial severity of paralysis, and number of days from onset of facial weakness to the start of medical treatment.
Thirty-two (73%) of 44 patients had a satisfactory outcome, and 12 (27%) had a nonsatisfactory recovery. Initial House-Brackmann grades V/VI and electroneurographically detected degeneration of 90% or more were shown to affect the long-term outcome of facial weakness significantly (p = 0.024 and p = 0.000, respectively).
The initial severity of facial weakness and the electroneurographically detected facial nerve degeneration were found to be important factors in predicting the long-term prognosis of Bell's palsy.</abstract><cop>United States</cop><pmid>21659930</pmid><doi>10.1097/mao.0b013e31821da2c6</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1531-7129 |
ispartof | Otology & neurotology, 2011-07, Vol.32 (5), p.848-851 |
issn | 1531-7129 1537-4505 |
language | eng |
recordid | cdi_proquest_miscellaneous_877405153 |
source | MEDLINE; Journals@Ovid Complete |
subjects | Adolescent Adult Aged Bell Palsy - drug therapy Bell Palsy - physiopathology Child Child, Preschool Dextrans - therapeutic use Facial Nerve - physiopathology Female Follow-Up Studies Glucocorticoids - therapeutic use Humans Male Middle Aged Pentoxifylline - therapeutic use Phosphodiesterase Inhibitors - therapeutic use Prednisolone - therapeutic use Prognosis Recovery of Function - physiology Severity of Illness Index Treatment Outcome |
title | Predicting the long-term outcome after idiopathic facial nerve paralysis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T09%3A23%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predicting%20the%20long-term%20outcome%20after%20idiopathic%20facial%20nerve%20paralysis&rft.jtitle=Otology%20&%20neurotology&rft.au=Mantsopoulos,%20Konstantinos&rft.date=2011-07&rft.volume=32&rft.issue=5&rft.spage=848&rft.epage=851&rft.pages=848-851&rft.issn=1531-7129&rft.eissn=1537-4505&rft_id=info:doi/10.1097/mao.0b013e31821da2c6&rft_dat=%3Cproquest_cross%3E877405153%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=877405153&rft_id=info:pmid/21659930&rfr_iscdi=true |